NCT00003210
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +51 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Adult Diffuse Large Cell Lymphoma
Explore clinical trials studying Recurrent Adult Diffuse Large Cell Lymphoma. Study availability and eligibility vary by location and protocol.
94 public trials
0 recruiting studies
Recurrent Adult Diffuse Large Cell Lymphoma trial results
NCT00343798
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +145 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- University of Colorado Denver, Colorado, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00082784
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +33 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina Charleston, South Carolina, United States
NCT01158274
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +151 more
- Locations
-
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
- Locations
-
- Chedoke-McMaster Hospitals Hamilton, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
NCT00110071
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
NCT00054639
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00290472
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Evanston Hospital CCOP Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
Completed
Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
NCT00058019
- Conditions
- Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT00392496
- Conditions
- Adult Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada